[Leprosy].
D001842:Bone and Bones / Q000473:pathology; D002991:Clofazimine / Q000627:therapeutic use; D006801:Humans; D007830:Larynx / Q000473:pathology; D007916:Lepromin; D007918:Leprosy / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D009092:Mucous Membrane / Q000473:pathology; D009166:Mycobacterium leprae; D009297:Nasal Mucosa / Q000473:pathology; D009443:Neuritis / Q000209:etiology; D010525:Peripheral Nerves / Q000473:pathology; D010614:Pharynx / Q000473:pathology; D011379:Prognosis; D012293:Rifampin / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D013450:Sulfones / Q000627:therapeutic use
D013450:Sulfones; D007916:Lepromin; D002991:Clofazimine; D012293:Rifampin
La lèpre.